Prognosis

A Fast-Moving Virus Pits Treating Patients Against Finding a Cure

The frenzied hunt for drugs to ease Covid-19 could make it more difficult for scientists to find lasting treatments

The drug remdesivir, made by Gilead Sciences, is one of several potential treatments for the novel coronavirus now being studied in clinical trials. — The drug remdesivir, made by Gilead Sciences, is one of several potential treatments for the novel coronavirus now being studied in clinical trials.
Photographer: David Paul Morris/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Robert Langreth and Riley Griffin

April 5, 2020 at 12:00 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Pharmaceutical-research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't.